Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30860405 | 1.00 | HIF1A (0.70) | HIF1AHSP90AA1 | |
| SCHEMBL21765950 | 0.89 | HIF1A (0.67) | HIF1AHSP90AA1 | |
| SCHEMBL21758149 | 0.87 | HIF1A (0.65) | HIF1AHSP90AA1 | |
| SCHEMBL31074346 | 0.87 | HIF1A (0.65) | HIF1AHSP90AA1 | |
| SCHEMBL30860222 | 0.85 | HIF1A (0.56) | HIF1AHSP90AA1 | |
| SCHEMBL31074344 | 0.84 | HIF1A (0.53) | HIF1AHSP90AA1 | |
| SCHEMBL18244767 | 0.82 | HIF1A (1.00) | HIF1AHSP90AA1 | |
| SCHEMBL30860187 | 0.82 | HIF1A (0.53) | HIF1AHSP90AA1 | |
| SCHEMBL30860274 | 0.79 | HIF1A (0.49) | HIF1AHSP90AA1 | |
| SCHEMBL30860214 | 0.79 | HIF1A (0.50) | HIF1AHSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4733300-A1 | NOVEL CHROMENE-BENZIMIDAZOLE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND USE THEREOF | Korea University Research and Business Foundation (KR) | 2026-04-29 | — | — | EP | disclosed |
| WO-2024263007-A1 | NOVEL CHROMENE-BENZIMIDAZOLE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND USE THEREOF | 고려대학교 산학협력단 | 2024-12-26 | — | — | WO | disclosed |
| WO-2020040582-A1 | NOVEL BENZOPYRAN DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS EFFECTIVE INGREDIENT | 고려대학교 산학협력단 | 2020-02-27 | — | — | WO | disclosed |